Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Not Yet Recruiting

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）

NCT07399444

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Not Yet Recruiting

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma

NCT05874193

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Johnston Hematology and Oncology of Clayton Clayton, North Carolina, United States
  • Maria Parham Hospital Henderson, North Carolina, United States
  • Scotland Health Care System Laurinburg, North Carolina, United States
  • UNC Health Southeastern Lumberton, North Carolina, United States
View Trial Details

Related conditions